Suppr超能文献

用于治疗腹泻的大米基口服补液盐溶液

Rice-based oral rehydration solution for treating diarrhoea.

作者信息

Fontaine O, Gore S M, Pierce N F

机构信息

Division of Child Health and Development, World Health Organization, Via Appia, 1211 - Geneva -27, Switzerland.

出版信息

Cochrane Database Syst Rev. 2000(2):CD001264. doi: 10.1002/14651858.CD001264.

Abstract

BACKGROUND

Oral rehydration therapy is used to treat dehydration caused by diarrhoea. However the rehydration solution does not reduce stool loss or length of illness. A solution able to do this may lessen the use of ineffective diarrhoea treatments as well as improve morbidity and mortality related to diarrhoea.

OBJECTIVES

The objective of this review was to assess the effects of rice-based oral rehydration salts solution compared with glucose-based oral rehydration salts solution on reduction of stool output and duration of diarrhoea in patients with acute watery diarrhoea.

SEARCH STRATEGY

We searched the Cochrane Infectious Diseases Group trials register, the Cochrane Controlled Trials Register, Medline, Embase, Lilacs and the reference lists of relevant articles. We also contacted researchers in the field.

SELECTION CRITERIA

Randomized trials comparing standard World Health Organization oral rehydration solution with an experimental oral rehydration salts solution in which glucose (20 grams per litre) was replaced by 50-80 grams per litre of rice powder, with the electrolytes remaining unchanged.

DATA COLLECTION AND ANALYSIS

Data were extracted independently by a statistician and a clinician.

MAIN RESULTS

Twenty-two trials were included. Concealment of allocation was adequate in 15 of these trials. Irrespective of age, people with cholera who were given rice oral rehydration salts solution had substantially lower rates of stool loss than those given oral rehydration salts solution in the first 24 hours. Mean stool outputs in the first 24 hours were lower by 67 millilitres/kg of body weight (weighted mean difference -67.4, 95% confidence interval -94.3 to -41.0) in children, and by 51 millilitres/kg of body weight (weighted mean difference -51.1, 95% confidence interval -65.9 to -36.3) in adults. The rate of stool loss in infants and children with acute non-cholera diarrhoea was reduced by only four millilitres/kg of body weight (weighted mean difference -4.3, 95% confidence interval -9.3 to 0.8).

REVIEWER'S CONCLUSIONS: Rice-based oral rehydration appears to be effective in reducing stool output in people with cholera. This effect was not apparent in infants and children with non-cholera diarrhoea.

摘要

背景

口服补液疗法用于治疗腹泻引起的脱水。然而,补液溶液并不能减少粪便排出量或缩短病程。一种能够做到这一点的溶液可能会减少无效腹泻治疗方法的使用,并改善与腹泻相关的发病率和死亡率。

目的

本综述的目的是评估与基于葡萄糖的口服补液盐溶液相比,基于大米的口服补液盐溶液对急性水样腹泻患者减少粪便排出量和腹泻持续时间的效果。

检索策略

我们检索了Cochrane传染病组试验注册库、Cochrane对照试验注册库、Medline、Embase、Lilacs以及相关文章的参考文献列表。我们还联系了该领域的研究人员。

选择标准

随机试验,比较标准的世界卫生组织口服补液溶液与实验性口服补液盐溶液,其中每升葡萄糖(20克)被每升50 - 80克米粉替代,电解质保持不变。

数据收集与分析

数据由一名统计学家和一名临床医生独立提取。

主要结果

纳入了22项试验。其中15项试验的分配隐藏充分。无论年龄如何,在最初24小时内,接受大米口服补液盐溶液的霍乱患者的粪便排出率明显低于接受口服补液盐溶液的患者。儿童在最初24小时内的平均粪便排出量每千克体重降低67毫升(加权平均差 -67.4,95%置信区间 -94.3至 -41.0),成人每千克体重降低51毫升(加权平均差 -51.1,95%置信区间 -65.9至 -36.3)。急性非霍乱腹泻的婴儿和儿童的粪便排出率仅每千克体重降低4毫升(加权平均差 -4.3,95%置信区间 -9.3至0.8)。

综述作者的结论

基于大米的口服补液似乎对减少霍乱患者的粪便排出量有效。这种效果在非霍乱腹泻的婴儿和儿童中并不明显。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验